Michal Marszal, CFA

Michal Marszal is a Portfolio Manager with Equities – Global Healthcare at CIBC Asset Management.

He is responsible for research coverage and stock selection within the global healthcare sector.

Prior to joining CIBC in 2017, Mr. Marszal was a consultant in healthcare equity research for Caisse de dépôt et placement du Québec. Previously, he was a senior analyst focusing on healthcare therapeutics at Lombard Odier Investment Managers. Mr. Marszal began his investment career as an analyst covering medical technology, and subsequently biotechnology companies at Sectoral Asset Management.

Mr. Marszal holds a Doctor of Medicine and Master of Surgery degree from McGill University. Upon graduating from medical school, he joined the Neurological Surgery Residency training program at Stanford University Medical Center as a resident physician. Mr. Marszal also holds an MBA degree in Finance from McGill University and a Bachelor of Arts degree in Molecular Biology from Bard College. He is a CFA charterholder and member of the CFA Society of Toronto.

Equities

Sponsored

Using Health-Care Stocks For Defensive Positioning

Most of the sector maintains demand across economic cycles, PM says.

By Michal Marszal, CFA |October 2, 2023

6 min read

Sponsored by

Equities

Sponsored

Health-Care Equities Outlook for 2023

Certain segments expected to perform better than others this year.

By Michal Marszal, CFA |January 30, 2023

5 min read

Sponsored by

Equities

Sponsored

Sell-Off Has Created Opportunities in Global Health Care

Valuations are looking more attractive for those who can handle the risk.

By Michal Marszal, CFA |May 25, 2022

4 min read

Sponsored by

Equities

Sponsored

How Inflation is Hitting the Health-Care Sector

Higher input costs are shrinking margins.

By Michal Marszal, CFA |May 18, 2022

4 min read

Sponsored by

Equities

Sponsored

Post-Pandemic Health-Care picks

Where the sector goes from here.

By Michal Marszal, CFA |January 24, 2022

3 min read

Sponsored by

Equities

Sponsored

How Pharma Companies Have Fared in the Pandemic

Pfizer and Moderna continue to come out on top.

By Michal Marszal, CFA |January 12, 2022

3 min read

Sponsored by

Equities

Sponsored

Investing Opportunities as Health Care Goes High Tech

Understanding innovation in the sector helps reveal top stocks.

By Michal Marszal, CFA |May 31, 2021

3 min read

Sponsored by